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Abstract The neural crest is a dynamic progenitor cell population that arises at the border of
neural and non-neural ectoderm. The inductive roles of FGF, Wnt, and BMP at the neural plate
border are well established, but the signals required for subsequent neural crest development
remain poorly characterized. Here, we conducted a screen in primary zebrafish embryo cultures for
chemicals that disrupt neural crest development, as read out by crestin:EGFP expression. We
found that the natural product caffeic acid phenethyl ester (CAPE) disrupts neural crest gene
expression, migration, and melanocytic differentiation by reducing Sox10 activity. CAPE inhibits
FGF-stimulated PI3K/Akt signaling, and neural crest defects in CAPE-treated embryos are
suppressed by constitutively active Akt1. Inhibition of Akt activity by constitutively active PTEN
similarly decreases crestin expression and Sox10 activity. Our study has identified Akt as a novel
intracellular pathway required for neural crest differentiation.
DOI: https://doi.org/10.7554/eLife.29145.001
Introduction
The neural crest is an embryonic progenitor cell population common to all vertebrates. These cells
are highly migratory and give rise to tissues canonically derived from both ectoderm and mesoderm,
including bone and cartilage of the head, peripheral neurons, and pigment cells. Neural crest specifi-
cation begins during gastrulation with the expression of neural plate border specifiers. As develop-
ment proceeds to the neurula stage, these transcription factors in turn regulate the expression of
neural crest specifiers, which mark cells that will migrate and differentiate into neural crest deriva-
tives (Sauka-Spengler and Bronner-Fraser, 2008). Not all neural plate border cells are fated to
become neural crest, raising the question of which signals regulate the decision between neural crest
and other ectodermal derivatives.
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In several cases the same signals that regulate neural plate border specification can later regulate
neural crest specification. Reiterated Wnt signaling plays a role in neural crest development in chicks,
frogs, zebrafish (Garcı´a-Castro et al., 2002; Monsoro-Burq et al., 2005; Lewis et al., 2004;
Sato et al., 2005). Wnt acts early in neural crest development to regulate expression of the neural
plate border genes pax3 and msx1, as well as later to allow pax3 and zic1 to activate transcription of
neural crest specifiers including foxd3 and slug (Lewis et al., 2004; Sato et al., 2005). BMP is also
reported to play a reiterated role in neural crest development. In Xenopus attenuation of BMP sig-
naling by Hairy2 upregulates neural plate border genes but inhibits neural crest genes
(Nichane et al., 2008).
While much work has contributed to our knowledge of morphogens required for neural crest
induction, less is known about the intracellular signals that are activated in response to these ligands.
Fibroblast growth factor (FGF) is reported to play both a cell autonomous and non-cell autonomous
role in neural crest induction, either by directly inducing neural crest gene expression or by inducing
Wnt8 expression in the paraxial mesoderm (Hong et al., 2008; Yardley and Garcı´a-Castro, 2012;
Stuhlmiller and Garcı´a-Castro, 2012). FGFs can activate four major intracellular pathways: MAPK,
AKT, PLCg, and STAT (Turner and Grose, 2010). Which of these are important during neural crest
has not been systematically addressed, though several studies have shown that MAPK signaling acts
downstream of FGF in early neural crest induction (Stuhlmiller and Garcı´a-Castro, 2012; Martı´nez-
Morales et al., 2011).
Akt, also referred to as protein kinase B, is a critical effector downstream of receptor tyrosine kin-
ases. Classically studied for its oncogenic properties, Akt and its upstream activator PI3-kinase (PI3K)
play an important role in cell survival and cell cycle progression. Akt also plays a role in the develop-
ment of many tissues, canonically acting through negative regulation of FoxO transcription factors
(Accili and Arden, 2004). The Akt pathway has been particularly well-studied in the context of myo-
genic differentiation, where it induces myoblast fusion (Jiang et al., 1998). Akt also regulates b-cate-
nin, promoting its transcriptional activity by both direct and indirect phosphorylation (Fang et al.,
2007).
In this study we took advantage of chemical screening in zebrafish to better understand pathways
regulating neural crest development. We developed a heterogeneous neural crest cell culture sys-
tem to screen for chemicals that specifically decrease expression of the neural crest marker crestin:
EGFP. We found that caffeic acid phenethyl ester (CAPE) inhibits expression of crestin by reducing
Sox10 activity. CAPE also disrupts neural crest migration and decreases formation of pigmented
melanocytes. We found that CAPE inhibits FGF-stimulated PI3K/Akt signaling in vitro, and expres-
sion of constitutively active Akt1 suppresses the effects of CAPE on the neural crest in vivo. Reduc-
tion of Akt activity by constitutively active PTEN similarly decreases crestin expression. We have
identified PI3K/Akt as a novel intracellular pathway required for neural crest differentiation through
regulation of Sox10 activity.
Results
An in vitro screen for chemicals that decrease crestin:EGFP expression
To better understand the signals essential for neural crest development, we looked for small mole-
cules that decreased expression of the neural crest reporter crestin_1 kb:EGFP (hereafter referred to
as crestin:EGFP). The 1 kb crestin promoter fragment recapitulates endogenous crestin mRNA
expression, thus marking the neural crest lineage in vivo (Kaufman et al., 2016). We developed a
neural crest culture protocol to facilitate rapid and automated chemical screening while maintaining
this transient cell population in heterogeneous cultures (Figure 1A,B) (Ciarlo and Zon, 2016). This
approach allowed us to distinguish broadly toxic chemicals from those with selective effects on the
neural crest. Crestin:EGFP; ubi:mCherry transgenic zebrafish embryos were grown to the 5 somite
stage (ss), mechanically homogenized, and plated on standard tissue culture-coated plastic in media
optimized for neural crest growth and survival, containing fetal bovine serum (FBS), epidermal
growth factor (EGF), fibroblast growth factor 2 (FGF2), and insulin (Kinikoglu et al., 2014). Under
these conditions, crestin:EGFP+ cells arose and proliferated, accounting for approximately 20% of
total cells after 24 hr in culture (Figure 1—figure supplement 1A–B). These cells were highly
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proliferative and migratory, expressed key neural crest genes, and could differentiate into pig-
mented melanocytes in vivo (Figure 1—figure supplement 1C–F and Video 1).
We used this primary cell culture system to screen 3400 compounds at two concentrations,
including bioactives libraries, FDA approved drugs, and Chembridge novel compounds. Chemical
hits were identified based on toxicity and specificity cutoffs, taking into account both total cell num-
ber as determined by Hoechst staining of nuclei and ubi:mCherry+ cells representing a random pop-
ulation of cells (Figure 1A,B). All hits were verified by eye, resulting in a hit rate of 1.0–1.8%. Of 86
non-redundant, commercially available hit chemicals, 72 reproduced a specific, dose-dependent
decrease in number of crestin:EGFP+ cells in culture (Figure 1C, Table 1). We next tested the effect































































Figure 1. Chemical screening in zebrafish embryonic cell cultures identifies inhibitors of neural crest development. (A) CAPE decreases crestin:EGFP
+ cells in culture while leaving ubi:mCherry+ cells unchanged. Scale bar: 100 mm. Characterization of cultured crestin:EGFP+ cells is shown in
Figure 1—figure supplement 1. (B) Chemical screen design. Whole embryos were mechanically homogenized and plated on standard tissue culture
coating in neural crest medium with chemicals. After 24 hr of culture, Hoechst 33342 was added to stain nuclei before imaging. (C) Screen hits were
validated in the primary screen assay and tested for an effect on crestin:EGFP expression in vivo. (D) Structure of CAPE. (E) CAPE shows a greater than
10-fold selectivity for crestin:EGFP+ cells versus ubi:mCherry+ cells in vitro.
DOI: https://doi.org/10.7554/eLife.29145.002
The following source data and figure supplements are available for figure 1:
Source data 1. Ubi:mCherry and crestin:EGFP+ cell numbers in CAPE-treated cultures.
DOI: https://doi.org/10.7554/eLife.29145.004
Figure supplement 1. Characterization of cultured crestin:EGFP+ cells.
DOI: https://doi.org/10.7554/eLife.29145.003
Figure supplement 1—source data 1. Percentage crestin:EGFP+ cells in culture.
DOI: https://doi.org/10.7554/eLife.29145.005
Figure supplement 1—source data 2. Cell migration speed.
DOI: https://doi.org/10.7554/eLife.29145.006
Figure supplement 1—source data 3. Fraction EdU+ cells.
DOI: https://doi.org/10.7554/eLife.29145.007
Figure supplement 1—source data 4. qPCR analysis of neural crest gene expression in cultured crestin:EGFP+ cells.
DOI: https://doi.org/10.7554/eLife.29145.008
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neural crest specification but after the neural
plate border is established. Sixteen chemicals
decreased crestin:EGFP in vivo, including CAPE,
a natural product with multiple reported biologi-
cal activities and targets (Figure 1D–E, Table 1).
CAPE disrupts neural crest gene
expression in vivo by reducing
Sox10 activity
Embryos treated with 10 mM CAPE at 2 ss
showed a consistent and dramatic reduction in
crestin:EGFP expression (Figure 2A). We saw a
similar effect using the minimal 296 base pair
crestin promoter (crestin_296bp:EGFP) (Fig-
ure 2—figure supplement 1A). To determine
whether CAPE affects crestin:EGFP during or
after neural crest specification, we conducted
time lapse microscopy of crestin:EGFP trans-
genic embryos. In treated embryos, crestin:
EGFP arose at a severely reduced level, and
most crestin:EGFP+ cells that did emerge
quickly disappeared, indicating that they had
either died or turned off crestin:EGFP expres-
sion (Videos 2 and 3). Time course experiments confirmed that CAPE acts quickly and early in neural
crest development. As determined by whole mount in situ hybridization (ISH), crestin expression was
decreased after two hours of CAPE treatment, and CAPE had no effect on crestin expression in
embryos treated at 15 ss or later (Figure 2—figure supplement 1B–C) .
We further analyzed the effect of CAPE on neural crest gene expression by ISH. Embryos were
treated with CAPE at 2 ss and fixed at 15–17 ss for analysis. We found a decrease in expression of
crestin, sox10, pax7a, dlx2a, and the Ap-2a target gene inka1a (Figure 2B,C). These genes are
expressed in both premigratory and migratory neural crest. We observed little to no change in the
levels of nr2f2, msxb, pax3a, ets1, ap2a, ap2c, snai1b, dlx5a, and foxd3 (Figure 2—figure supple-
ment 2A,B). In addition to being expressed in the premigratory and migratory neural crest, a subset
of these genes are expressed earlier in development at the neural plate border (msxb, pax3a,
dlx5a). Our data indicate that neural crest-like cells are present in CAPE-treated embryos but exhibit
abnormal gene expression, particularly for genes expressed after the neural plate border is estab-
lished. Later in development, at 24 hpf, CAPE treatment caused a dramatic decrease in pigment
cell-specific gene expression, including mitfa and its target gene dct, which mark melanoblasts, and
fms, which marks xanthophore precursors (Figure 2D).
To confirm that changes in neural crest gene expression were not the result of reduced cell num-
ber, we evaluated proliferation and cell death in CAPE-treated embryos. After 6 hr of treatment, a
time point at which neural crest gene expression is decreased by CAPE, no change in proliferation
was observed in sox10:GFP+ cells, as determined by phospho-histone H3 staining (Figure 2—figure
supplement 3A,B). To evaluate cell death, we used whole mount TUNEL staining combined with
crestin ISH. We found a slightly increased number of overall TUNEL positive cells in embryos treated
with 10 mM CAPE for 6 hr, but these cells were not present in the region of crestin expression, and
the magnitude of increased cell death does not explain the differences in crestin expression (Fig-
ure 2—figure supplement 3C,D). After 19 hr of treatment, 10 mM CAPE increased cell death
broadly throughout the embryo, most dramatically in the eye and tail, while 5 mM CAPE had no
effect on cell death, even as late as 48 hpf (Figure 2—figure supplement 3E,F). These data indicate
that increased cell death or reduced proliferation do not contribute to the early effects of CAPE on
neural crest gene expression. The observed deficiency in pigment cell gene expression is also not
explained by increased cell death, since this deficiency was observed with 5 mM CAPE treatment.
To confirm CAPE’s effect on neural crest gene expression and identify potential mechanisms of
action, we conducted RNA-seq on sorted sox10:Kaede+ cells from control and CAPE-treated
embryos at 17 ss. This data confirmed that neural crest gene expression is decreased in cells from
Video 1. Crestin:EGFP time lapse in heterogeneous
neural crest cultures.
DOI: https://doi.org/10.7554/eLife.29145.009
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Table 1. In vitro validated screen hits.
Hits that also validated in vivo are bold.
Compound Library Target/category
CAPE ICCB NFkB/multiple
raloxifene LOPAC Estrogen receptor
mianserin LOPAC 5-HT receptor antagonist
GANT61 LOPAC Hedgehog
MnTBAP ICCB SOD mimetic
loperamide FDA
approved




tetraethylthiuram disulfide LOPAC alcohol dehydrogenase
dopamine LOPAC dopamine receptor
mycophenolate mofetil LOPAC IMPH















capsazepine LOPAC sodium channels








indatraline LOPAC dopamine uptake inhibitor
MBCQ ICCB PDE5
MDL-28170 ICCB calpain inhibitor
NS8593 LOPAC potassium channels
NU6027 LOPAC ATR/CDK2 inhibitor
PD180970 LOPAC RTK inhibitor
PD173074 LOPAC src inhibitor
PI-103 LOPAC PI3K
rapamycin LOPAC mTOR




tyrphostin AG698 LOPAC tyrosine kinase inhibitor
wiskostatin LOPAC actin
PAC-1 LOPAC proapoptotic zinc chelator
PD407824 LOPAC chk1 inhibitor
Table 1 continued on next page
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CAPE-treated embryos, though to a lesser extent than observed in ISH experiments (Figure 2E).
Some genes including pax3a and nr2f2 appeared unchanged by in situ but were downregulated in
RNA-seq data (Figure 2—figure supplement 2C). Sox10:Kaede is more highly expressed in the cra-
nial than trunk neural crest and is also highly expressed in the otic vesicle, potentially explaining the
discrepancies between RNA-seq and ISH results. Consistent with ISH at 24 hpf, CAPE decreased
Table 1 continued
Compound Library Target/category
PD173952 LOPAC src inhibitor
sanguinarine LOPAC Na/K ATPase
tyrphostin AG835 LOPAC EGFR
(-)-alpha-methylnorepinephrine LOPAC sympathomimetic
chloroquine LOPAC antimalarial
M-344 LOPAC HDAC inhibitor
olmesartan medoxomil FDA
approved
angiotensin II receptor antagonist
1,10-phenanthroline LOPAC chelator, MMP
2,3-dimethoxy-1,4-naphthoquinone LOPAC ROS





SAHA LOPAC HDAC inhibitor
nimesulide LOPAC COX-2
mibefradil LOPAC calcium channels
KB-R7493 LOPAC sodium calcium exchanger
LY165163 LOPAC 5-HT receptor antagonist
dequalinium LOPAC potassium channels
AM92016 ICCB potassium channels
2-[4-(1,3-benzodioxol-5-yl) 1H-pyrazol-1-yl]-N-(2-ethyl-2H-1,2,3-triazol-4-yl)acetamide Chembridge predicted adenosine kinase
N-(2-ethyl-2H-1,2,3-triazol-4-yl) 2-{4-[3-(1H-pyrazol-1-yl)phenyl] 1H-pyrazol-1-yl}acetamide Chembridge predicted adenosine kinase
2,2,6,6-tetramethyl-N-(1-methyl-3-phenylpropyl) 4-piperidinamine Chembridge predicted vitamin D receptor
N-[(5-chloro-1H-indol-2-yl)methyl] 2-(3-hydroxyphenyl)acetamide Chembridge predicted TK(FLT3)
5-(1H-indol-2-ylcarbonyl) 4,5,6,7-tetrahydrothieno[3,2 c]pyridine Chembridge predicted TK(FLT3)
1-acetyl-4-{4-[1-(2-fluorophenyl) 1H-pyrazol-4-yl]pyrimidin-2-yl} 1,4-diazepane Chembridge predicted JNK
4-(4-butyl-1H-1,2,3-triazol-1-yl) 1-{[(1S*,4S*) 3,3-dimethyl-2-methylenebicyclo[2.2.1]hept-1-yl]
carbonyl}piperi
Chembridge predicted liver X receptor
1-(3-methylbenzyl) 4-thieno[2,3-d]pyrimidin-4-yl-2-piperazinone Chembridge predicted TK(EGFR, PDGFR,
CSFR1); PKC; PKA
1-(2-methoxyphenyl) 2,2-dimethyl-4-(4-methylpentanoyl)piperazine Chembridge predicted androgen receptor
5,6-dimethyl-2-[4-({methyl[(2-methylpyridin-4-yl)methyl]amino}methyl)phenyl]pyrimidin-4(3 hr)-one Chembridge predicted estrogen receptor
N-[1-(1,5-dimethyl-1H-pyrazol-4-yl)ethyl]thieno[2,3-d]pyrimidin-4-amine Chembridge predicted EGFR
N-(1-cyclohexyl-1H-pyrazol-5-yl) 2-[3-(2-thienyl) 1H-pyrazol-1-yl]acetamide Chembridge predicted VEGFR2, EGF/KDR
2-[1-(3-isobutyl-1,2,4-oxadiazol-5-yl) 2-methylbutyl] 1-isoindolinone Chembridge predicted RAR(gamma)
1-propyl-N-{1-[4-(1H-pyrazol-1-yl)phenyl]piperidin-4-yl}piperidin-4-amine Chembridge predicted estrogen receptor
5-[5-methyl-4-(1-methyl-1H-pyrazol-4-yl)pyrimidin-2-yl] 4,5,6,7-tetrahydrothieno[3,2 c]pyridine Chembridge predicted TK(VEGFR, KDR, FLK1)
2-[5-(2,6-dimethylphenyl) 1H-indazol-1-yl]-N-(1,3-dimethyl-1H-pyrazol-5-yl)acetamide Chembridge predicted TK(PDGFR, EGFR,
FGFR)
DOI: https://doi.org/10.7554/eLife.29145.010
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Figure 2. CAPE decreases neural crest gene expression. (A) CAPE dramatically reduces crestin:EGFP expression at 26 hpf. Figure 2—figure
supplement 1 shows the response of a smaller (396 bp) crestin promoter fragment to CAPE and the timing of crestin response to CAPE. (B) CAPE
decreases neural crest gene expression as determined by whole mount in situ hybridization (ISH) at 15–17 ss. Expression of some genes is decreased
ubiquitously while others are only altered in specific anatomic locations (arrows). Images are representative of at least two independent experiments.
(C) Scoring of ISH in (B). (D) CAPE reduces expression of pigment cell genes at 24 hpf. (E) FPKM values from RNA-sequencing of sox10:Kaede+ cells
Figure 2 continued on next page
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expression of melanocyte-specific genes including mitfa, ednrba, and tyr (Figure 2E). Ingenuity Path-
way Analysis (Qiagen) pointed to an increase in inflammatory signaling and changes in levels of
morphogens such as Wnts, BMPs, and FGFs with CAPE treatment (Figure 2—figure supplement 4).
These results suggest that CAPE’s mechanism of action involves cell-cell signaling at the level of
secreted ligand expression.
To better understand the mechanism by which CAPE leads to changes in gene expression, we
conducted ATAC-seq (Assay for Transposase-Accessible Chromatin) in sox10:Kaede+ cells isolated
from control and CAPE-treated embryos (Buenrostro et al., 2013). We observed a reduction in
chromatin accessibility specifically at the mitfa promoter with CAPE treatment (Figure 3A). Changes
in mitfa expression and chromatin accessibility could be downstream of Sox10, as Sox10 is known to
bind to the promoter of mitfa and regulate its expression (Elworthy et al., 2003). Indeed, ChIP-seq
in a zebrafish melanoma cell line (zcrest 1) showed strong Sox10 binding at the mitfa promoter
Figure 2 continued
confirmed decreases in neural crest genes, though to a lesser extent than by ISH. Cells were sorted from control or CAPE-treated embryos at 17 ss.
Figure 2—figure supplement 2 shows neural crest genes with no significant change by ISH. Figure 2—figure supplement 3 shows that a change in
cell number does not account for neural crest gene expression changes. Figure 2—figure supplement 4 shows other gene expression changes in
neural crest cells. *p<0.001, **p<0.0001, chi-square test.
DOI: https://doi.org/10.7554/eLife.29145.011
The following source data and figure supplements are available for figure 2:
Source data 1. Expression of neural crest genes by ISH in CAPE-treated embryos.
DOI: https://doi.org/10.7554/eLife.29145.016
Figure supplement 1. Crestin_296bp:EGFP expression in CAPE-treated embryos and time course of CAPE treatment.
DOI: https://doi.org/10.7554/eLife.29145.012
Figure supplement 1—source data 1. Scoring of crestin_296bp:EGFP expression in CAPE-treated embryos.
DOI: https://doi.org/10.7554/eLife.29145.017
Figure supplement 2. Neural crest genes not significantly affected by CAPE treatment as determined by ISH.
DOI: https://doi.org/10.7554/eLife.29145.013
Figure supplement 2—source data 1. Scoring of neural crest gene expression by ISH in CAPE-treated embryos.
DOI: https://doi.org/10.7554/eLife.29145.018
Figure supplement 3. Changes in cell number do not explain reduced crestin expression in CAPE-treated embryos.
DOI: https://doi.org/10.7554/eLife.29145.014
Figure supplement 3—source data 1. PH3+ cells in sox10:GFP+ region of CAPE-treated embryos.
DOI: https://doi.org/10.7554/eLife.29145.019
Figure supplement 3—source data 2. TUNEL+ cells in neural crest region of CAPE-treated embryos.
DOI: https://doi.org/10.7554/eLife.29145.020
Figure supplement 4. Analysis of gene expression changes in sox10:Kaede+ cells by RNA-seq, comparing DMSO- to CAPE-treated embryos.
DOI: https://doi.org/10.7554/eLife.29145.015
Video 2. Crestin:EGFP expression in DMSO-treated
zebrafish embryos. Embryos were treated at 2 ss and
mounted for imaging at 10 ss. Embryos were imaged
for 16.25 hr, and images were collected every 9 min.
DOI: https://doi.org/10.7554/eLife.29145.021
Video 3. Crestin:EGFP expression in CAPE-treated (10
mM) zebrafish embryos. Embryos were treated at 2 ss
and mounted for imaging at 10 ss. Embryos were
imaged for 16.25 hr, and images were collected every 9
min.
DOI: https://doi.org/10.7554/eLife.29145.022
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(Figure 3A) (Kaufman et al., 2016). Other Sox10-bound genes including crestin did not show a
reduction in chromatin accessibility even though their expression was decreased (Figure 3B). There-
fore chromatin closing is likely not the primary mechanism by which CAPE decreases gene expres-
sion, but we used the ATAC-seq dataset to identify transcription factors of potential importance to
CAPE’s mechanism.
To identify transcription factors that could mediate CAPE’s effects on gene expression in a
genome-wide unbiased manner, we used Hypergeometric Optimization of Motif EnRichment
(HOMER) (Heinz et al., 2010). Of 81,140 total ATAC peaks, we identified 585 peaks (0.7%) unique
to the DMSO control sample as compared to the CAPE-treated sample. We used these peak
sequences as input to HOMER, with all peak sequences in the CAPE-treated sample as background.
The most enriched motifs were those of Sox transcription factors, including Sox10, and MITF
(Figure 3C). To determine whether CAPE affects Sox10 transcriptional activity, we overexpressed
sox10 in zebrafish embryos by RNA microinjection. While sox10 injection increased crestin:EGFP
expression in untreated embryos, it had no effect on crestin:EGFP expression in CAPE-treated
embryos, indicating that CAPE reduces Sox10 activity (Figure 3D–E). Reduced expression of crestin:
EGFP in CAPE-treated embryos was not due to a reduction in sox10-expressing cells, as the percent-
age of sox10:Kaede+ cells was identical in treated and control embryos (Figure 3—figure supple-
ment 1C). In contrast to sox10, injection of tfap2c RNA increased crestin:EGFP in both control and
CAPE-treated embryos, though its effect was subtle in both cases (Figure 3—figure supplement
1A,B). These data support a role for Sox10 in mediating the transcriptional effects of CAPE.
CAPE inhibits neural crest migration and pigment cell differentiation in
vivo
We found that neural crest migration is also disrupted by CAPE. While crestin:EGFP is dramatically
reduced upon CAPE treatment, sox10:GFP intensity is indistinguishable between control and treated
embryos. This may be due to the strength of the sox10 promoter or persistence of stable GFP.
Sox10:GFP transgenic embryos allowed us to follow neural crest cells after CAPE treatment. These
cells failed to reach the ventral half of the trunk in CAPE-treated embryos (Figure 4A, Videos 4 and
5). The cells remained rounded instead of extending projections and elongating ventrally, as was
observed in control embryos (Videos 4 and 5). At 2 days post fertilization (dpf), pigmentation in
CAPE-treated embryos was dramatically reduced, indicating that CAPE interferes with the produc-
tion of differentiated melanocytes (Figure 4B,C). A migration defect was also apparent in the
increased fraction of dorsal melanocytes at 2 dpf (Figure 4D). We found that CAPE’s effect on neu-
ral crest migration co-occurred with decreased mitfa:GFP expression. A melanocyte migration defect
was still evident when embryos were treated with CAPE at 15 ss (Figure 4D). Therefore the melano-
cyte migration defect induced by CAPE may be downstream of decreased mitfa expression.
We further evaluated the effect of CAPE on xanthophores and iridophores at 3 dpf. We found
that CAPE reduces iridophore number, size, and pigmentation, though this effect was not as dra-
matic as the effect of CAPE on melanocytes (Figure 4—figure supplement 1A,B). As for melano-
cytes, we saw an increase in the fraction of dorsal iridophores, but this effect was again less
pronounced than the melanocyte position defect (Figure 2D, Figure 4—figure supplement 1C).
Though we saw reduced fms expression at 24 hpf, we found that by 3 dpf, xanthophores had recov-
ered. CAPE-treated embryos in fact showed more intense yellow pigmentation that control embryos,
particularly in the head (Figure 4—figure supplement 1A). These data indicate that CAPE treatment
has selective effects on different pigment cell lineages.
Since Sox10 plays an important role in otic placode development, we evaluated the effect of
CAPE on the otic vesicle at 24 and 48 hpf (Dutton et al., 2009). We found that CAPE causes a sub-
tle defect in otic vesicle shape at 24 hpf. At 48 hpf, CAPE-treated embryos lack semicircular canal
projections and have more closely spaced otoliths (Figure 4—figure supplement 2). These defects
are consistent with a reduction in Sox10 activity, since they have been observed in sox10 mutants
(Dutton et al., 2009).
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Figure 3. CAPE reduces Sox10 activity. (A) ATAC-seq was conducted on sox10:Kaede+ cells from DMSO- or CAPE-treated embryos at two stages.
CAPE reduces chromatin accessibility at the mitfa promoter in sox10:Kaede+ cells, and Sox10 binds the mitfa promoter in a zebrafish tumor cell line. (B)
Crestin binds Sox10 but does not show a change in chromatin accessibility with CAPE treatment. Bar indicates region of crestin sequence similarity
(chr4:41,270,000). (C) HOMER analysis of 20 ss ATAC-seq peaks revealed an enrichment for Sox and MITF motifs when comparing unique peaks in
DMSO-treated embryos (% target) to all peaks in CAPE-treated embryos (% background). (D) CAPE (5 mM) prevents sox10 RNA (30 pg) from increasing
crestin:EGFP expression. (E) Quantification of experiment shown in (D). Sum of three clutches from two independent experiments is shown. Figure 3—
figure supplement 1 shows that tfap2c RNA increases crestin:EGFP expression in both DMSO- and CAPE-treated embryos, and that the number of
sox10:Kaede+ cells does not change with CAPE treatment.
DOI: https://doi.org/10.7554/eLife.29145.023
The following source data and figure supplements are available for figure 3:
Source data 1. Scoring of crestin:EGFP expression in sox10-injected and CAPE-treated embryos.
DOI: https://doi.org/10.7554/eLife.29145.025
Figure supplement 1. Tfap2c RNA injection (120 pg) increases crestin:EGFP expression in both control and CAPE-treated embryos.
DOI: https://doi.org/10.7554/eLife.29145.024
Figure supplement 1—source data 1. Scoring of crestin:EGFP expression in tfap2c-injected and CAPE-treated embryos.
Figure 3 continued on next page
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Inhibition of Akt signaling contributes to CAPE-induced defects in
neural crest development
CAPE has previously been reported to inhibit Akt signaling in melanoma cell lines by inhibition of
PI3K activity (Pramanik et al., 2013). In addition to CAPE, we identified the PI3K inhibitors PI-103
and GDC-0941 as strong hits in our screen and confirmed that they specifically reduce crestin:EGFP
+ cell number in a dose-responsive manner (Figure 5—figure supplement 1A). To determine
whether inhibition of Akt signaling might contribute to the effects of CAPE on the zebrafish neural
crest, we overexpressed constitutively active, membrane-targeted human Akt1 (myr-Akt1) in zebra-
fish embryos by RNA microinjection. Injection of myr-Akt1 increased Akt phosphorylation indepen-
dent of CAPE treatment and rescued crestin expression in CAPE-treated embryos (Figure 5A–C).
Myr-Akt1 injection also partially rescued both melanocyte number and melanocyte migration at 2
dpf (Figure 5D–F). Defects such as pericardial edema and curved tail showed a slight but consistent
decrease with myr-Akt1 injection (Figure 5—figure supplement 1B). Overall these data indicate
that inhibition of Akt signaling contributes to CAPE’s effects on both gene expression and migration
of neural crest cells.
To more precisely elucidate the mechanism of Akt inhibition by CAPE, we returned to the in vitro
culture system we used for chemical screening. This system provides an opportunity to control chem-
ical cues received by prospective neural crest cells. In addition to FBS, which contains unknown fac-
tors required for neural crest induction in vitro, two growth factors in the culture medium promoted
neural crest induction: FGF2 and insulin (Figure 6A,B). We studied two pathways known to be acti-
vated downstream of these factors: PI3K/Akt and Mek/Erk. We found that while insulin primarily acti-
vated Akt, FGF primarily activated Erk (Figure 6C,D).
Surprisingly, we found that CAPE inhibited Akt phosphorylation only in the presence of FGF,
even though FGF itself did not promote Akt activation (Figure 6C, Figure 6—figure supplement
1A). This was not true for the PI3K inhibitor PI-103 that prevented Akt phosphorylation regardless of
FGF stimulation (Figure 6—figure supplement 1C). We hypothesized that the apparent lack of Akt
stimulation by FGF could be explained by Akt inhibition by another pathway. Addition of a Mek
inhibitor to the cultures resulted in a dramatic increase in p-Akt, leading us to postulate that Mek/
Erk negatively regulates PI3K/Akt (Figure 6—figure supplement 1A, last two lanes). In the context
of Mek inhibition, we saw that FGF activated Akt to a similar extent as insulin (Figure 6—figure sup-
plement 1A, first three lanes). FGF treatment enhanced the ability of Mek inhibition to stimulate
p-Akt (Figure 6—figure supplement 1A, compare lanes 4 and 6). Mek inhibition also blunted the
ability of CAPE to reduce p-Akt (Figure 6—figure supplement 1B, compare lanes 2 and 6). Finally,
the induction of p-Akt by Mek inhibition was PI3K-dependent, since it was blocked by a PI3K inhibi-
tor (Figure 6—figure supplement 1B, lanes 1–4). These observations led us to formulate a model in
which FGF modulates Akt activation through a mechanism distinct from insulin-stimulated Akt activa-
tion and sensitive to CAPE activity (Figure 6—figure supplement 1D). Since the phosphorylation of
membrane-targeted Akt1 (myr-Akt1) is not affected by CAPE, CAPE acts upstream of Akt membrane
recruitment by PIP3 (Figure 5A). CAPE could function through inhibition of PI3K or activation of
Pten, a negative regulator of PIP3. We ruled out the latter hypothesis, since CAPE had the same
effect on crestin expression in wild type or ptena-/-;ptenb-/- embryos (Figure 6—figure supplement
1E).
While FGF2 and insulin were used to induce neural crest in culture, we asked what growth factors
regulate neural crest development in vivo. Many kinase inhibitors scored as hits in our initial screen,
including two chemicals from the Chembridge KINAcore library that were generated as structural
analogs to receptor tyrosine kinase (RTK) inhibitors. These two chemicals also decreased crestin
expression in vivo, while EGFR, FGFR, insulin-like growth factor receptor, and insulin receptor inhibi-
tors had no effect when added at 2 ss (Figure 6—figure supplement 2). Importantly we tested
SU5402, an FGFR inhibitor with demonstrated activity in zebrafish embryos (Molina et al., 2007).
This data suggests that a growth factor other than FGF activates Akt in neural crest cells in vivo.
Figure 3 continued
DOI: https://doi.org/10.7554/eLife.29145.026
Figure supplement 1—source data 2. Percentage sox10:Kaede+ live cells in CAPE-treated embryos.
DOI: https://doi.org/10.7554/eLife.29145.027
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Figure 4. CAPE inhibits neural crest migration and pigment cell differentiation. Embryos were treated at 2 ss unless otherwise indicated. (A) Sox10:
Kaede+ cells in the trunk of zebrafish embryos are more dorsally located at 24 hpf. Dotted line indicates top of yolk sac extension. CAPE-treated
embryos were allowed to develop for 4 hr longer than control embryos for stage matching. Numbers indicate fraction of embryos for which images are
representative. Some DMSO control embryos showed a pattern similar to 5 mM CAPE. Similar results were observed in three independent experiments.
(B) Morphology and pigmentation of CAPE-treated embryos at 2 dpf. Treated embryos showed reduced pigmentation and defects such as pericardial
edema and a curved tail. (C) Melanocyte counts corresponding to (B). Trunk melanocytes were counted from the yolk sac extension to the end of the
tail. Error bars represent standard deviation of 10 embryos from two independent experiments. (D) CAPE increases the fraction of dorsal melanocytes
at 2 dpf. Melanocytes were counted as in (C). Embryonic stage at drug treatment is indicated. *p<0.05, **p<0.0005, unpaired t-test. Figure 4—figure
supplement 1 shows the effect of CAPE on xanthophores and iridophores at 3 dpf. Figure 4—figure supplement 2 shows the effect of CAPE on otic
vesicle development.
DOI: https://doi.org/10.7554/eLife.29145.028
The following source data and figure supplements are available for figure 4:
Source data 1. Melanocyte numbers in CAPE-treated embryos.
DOI: https://doi.org/10.7554/eLife.29145.031
Source data 2. Fraction dorsal melanocytes in CAPE-treated embryos.
DOI: https://doi.org/10.7554/eLife.29145.032
Figure supplement 1. CAPE disrupts iridophore development less dramatically than melanocyte development.
DOI: https://doi.org/10.7554/eLife.29145.029
Figure supplement 1—source data 1. Number of iridophores in CAPE-treated embryos.
DOI: https://doi.org/10.7554/eLife.29145.033
Figure supplement 1—source data 2. Fraction dorsal iridophores in CAPE-treated embryos.
DOI: https://doi.org/10.7554/eLife.29145.034
Figure supplement 2. CAPE disrupts ear development.
DOI: https://doi.org/10.7554/eLife.29145.030
Ciarlo et al. eLife 2017;6:e29145. DOI: https://doi.org/10.7554/eLife.29145 12 of 26
Research article Developmental Biology and Stem Cells
Akt signaling regulates neural crest gene expression in vivo
To confirm that Akt activation plays a role in zebrafish neural crest development, we expressed con-
stitutively active human PTEN-mCherry fusion (PTEN S370A, S380A, T382A, T383A, S385A or PTEN
QMA) in crestin:EGFP transgenic zebrafish embryos (Gil et al., 2006; Stumpf et al., 2016). After
sorting embryos based on mCherry fluorescence at 24 hpf, we found that PTEN QMA-mCherry
decreases both phospho-Akt and crestin:EGFP expression (Figure 7A–C). We found a similar
decrease in crestin expression by ISH (Figure 7D). The PI3K inhibitor LY294002 also decreased cres-
tin:EGFP expression in vivo in a dose responsive manner (Figure 7E). Similar to CAPE treatment, we
found that co-injection of PTEN QMA prevented sox10 from stimulating crestin:EGFP expression
(Figure 7F–G). These data support a role for Akt activation in Sox10-dependent neural crest gene
transcription.
Discussion
Neural plate border cells have the capacity to form both neural and non-neural ectodermal deriva-
tives in addition to neural crest cells. While neural plate border specifiers direct expression of neural
crest specifiers, the role of additional cues in promoting neural crest specifier expression and activity
are poorly characterized. In this study, we used in vitro chemical screening to establish a key role for
PI3K/Akt signaling in neural crest development.
Chemical screening in zebrafish provided several advantages over traditional approaches. First,
we used an in vitro screening system that facilitated automation, minimized the time-dependency of
neural crest gene expression, and maintained cell type heterogeneity. Second, we treated zebrafish
embryos at a developmental time point when the neural plate border is already established. Third,
we avoided a common limitation of genetic studies in which isoform redundancy masks a phenotype
in loss-of-function studies.
We found that CAPE treatment and subsequent inhibition of Akt signaling decreased expression
of neural crest genes and led to a failure of neural crest cells to migrate. CAPE also reduced the
number of pigmented melanocytes in zebrafish embryos. CAPE-treated embryos exhibited severe
defects or death after more than two days of development, confounding analysis of other neural
crest derivatives such as peripheral neurons and cartilage. Though CAPE has many reported activi-
ties, we found that inhibition of Akt signaling was relevant for its effects on the neural crest. In
CAPE-treated embryos, constitutively active Akt1 rescued crestin expression, melanocyte number,
and melanocyte migration.
We further used neural crest selective cell cultures to investigate CAPE’s mechanism of action in
the context of particular growth factor stimulation. Although FGF itself did not appear to stimulate
Akt phosphorylation, FGF was required for the activity of CAPE. We hypothesized that FGF could
activate both PI3K/Akt and Mek/Erk pathways, but that Mek/Erk activation leads to PI3K/Akt cross-
inhibition, as has been previously published (Yu et al., 2002; Turke et al., 2012;
Video 4. Neural crest migration in DMSO-treated
zebrafish embryos. Sox10:GFP transgenic embryos
were treated at 2 ss and mounted for imaging at 15 ss.
Embryos were imaged for 12 hr, and images were
collected every 10 min.
DOI: https://doi.org/10.7554/eLife.29145.035
Video 5. Neural crest migration in CAPE-treated (10
mM) zebrafish embryos. Sox10:GFP transgenic embryos
were treated at 2 ss and mounted for imaging at 15 ss.
Embryos were imaged for 12 hr, and images were
collected every 10 min.
DOI: https://doi.org/10.7554/eLife.29145.036
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Figure 5. Myr-Akt1 rescues neural crest defects caused by CAPE. (A) Injection of myr-Akt1 RNA results in high phospho-Akt in heterogeneous neural
crest cultures regardless of CAPE treatment. The same result was observed in four independent experiments. (B) Scoring system for crestin in situ
hybridization. (C) Myr-Akt1 injection increases crestin expression in CAPE-treated embryos. Each point represents the average score of embryos from a
single clutch (23–66 embryos per clutch). Three independent experiments are shown. (D) Morphology and pigmentation of CAPE-treated and injected
embryos at 2 dpf. Images are representative of three independent experiments. (E) Myr-Akt1 increases melanocyte number in CAPE-treated embryos.
Trunk melanocytes were counted as in Figure 4. Each point represents one embryo from the same clutch; bars indicate mean. (F) Myr-Akt1 reduces the
fraction of dorsal melanocytes in CAPE-treated embryos. *p<0.05, **p<0.005, (C) paired t-test, (E–F) unpaired t-test. Figure 5—figure supplement 1
shows the effect of PI3K inhibitors on crestin:EGFP expression in vitro and the effect of myr-Akt1 on CAPE-induced embryonic defects.
DOI: https://doi.org/10.7554/eLife.29145.037
The following source data and figure supplements are available for figure 5:
Source data 1. Scoring of crestin expression by ISH in CAPE-treated and myr-Akt1-injected embryos.
DOI: https://doi.org/10.7554/eLife.29145.039
Source data 2. Melanocyte numbers in CAPE-treated and myr-Akt1-injected embryos.
DOI: https://doi.org/10.7554/eLife.29145.040
Source data 3. Melanocyte numbers in CAPE-treated and myr-Akt1-injected embryos.
DOI: https://doi.org/10.7554/eLife.29145.041
Figure supplement 1. Effect of PI3K inhibitors on crestin:EGFP expression in vitro and effect of myr-Akt1 injection on CAPE-induced defects.
DOI: https://doi.org/10.7554/eLife.29145.038
Figure supplement 1—source data 1. Ubi:mCherry+ and crestin:EGFP+ cell numbers in cultures treated with PI-103.
DOI: https://doi.org/10.7554/eLife.29145.042
Figure supplement 1—source data 2. Ubi:mCherry+ and crestin:EGFP+ cell numbers in cultures treated with GDC0941.
DOI: https://doi.org/10.7554/eLife.29145.043
Figure supplement 1—source data 3. Developmental defects in CAPE-treated and myr-Akt1-injected embryos.
DOI: https://doi.org/10.7554/eLife.29145.044
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Figure 6. CAPE inhibits FGF-stimulated Akt activation in vitro. Embryos were plated in neural crest medium and cultured for 2 hr for western blotting.
(A) Heterogeneous neural crest cultures after 24 hr in neural crest medium with or without FGF and insulin. Scale bar: 100 mm. Images are
representative of three independent experiments. (B) Quantification of crestin:EGFP+ cells for (A). Number of cells was determined by thresholding and
normalized to ubi:mCherry fluorescence representing total cell number. Mean and standard deviation of at least 4 wells is shown. (C) Ratio of
phosphorylated to total Akt. Each point represents an independent experiment corresponding to color. Samples were normalized within an experiment
so that p-Akt to Akt ratio with FGF and insulin but without CAPE (condition 5) had a value of 1. Insulin but not FGF stimulation leads to Akt
phosphorylation. CAPE inhibits Akt only in FGF-stimulated cells. (D) Ratio of phosphorylated to total Erk. Values were normalized as in (C). FGF but not
insulin stimulation leads to Erk phosphorylation. ‡ no signal detected *p<0.05, **p<0.005, ***p<0.0005, paired t-test. Figure 6—figure supplement 1
shows a model for CAPE’s mechanism of action based on the effects of a Mek inhibitor (CI-1040) and a PI3K inhibitor (PI-103) on Akt and Erk
phosphorylation. Figure 6—figure supplement 2 shows the effect of RTK inhibitors on crestin expression in vivo.
DOI: https://doi.org/10.7554/eLife.29145.045
The following source data and figure supplements are available for figure 6:
Source data 1. Number of crestin:EGFP+ cells per total ubi:mCherry fluorescence.
DOI: https://doi.org/10.7554/eLife.29145.048
Source data 2. Quantification of p-Erk/Erk and p-Akt /Akt ratios by western blot and densitometry.
DOI: https://doi.org/10.7554/eLife.29145.049
Figure supplement 1. CAPE inhibits FGF-stimulated Akt activation.
DOI: https://doi.org/10.7554/eLife.29145.046
Figure supplement 1—source data 1. Scoring of crestin expression by ISH in pten mutant embryos.
DOI: https://doi.org/10.7554/eLife.29145.050
Figure supplement 2. RTK signaling regulates crestin expression.
DOI: https://doi.org/10.7554/eLife.29145.047
Figure 6 continued on next page
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Zmajkovicova et al., 2013; Menges and McCance, 2008). This hypothesis was supported by a dra-
matic increase in Akt phosphorylation upon Mek inhibition (Figure 6—figure supplement 1A). We
formulated a model in which FGF modulates Akt activation depending on the level of Mek/Erk activ-
ity (Figure 6—figure supplement 1D). FGF stimulation acts like a pendulum that can swing between
PI3K/Akt activation or Mek/Erk activation. Under baseline conditions, FGF stimulation has no net
effect on Akt phosphorylation, since FGF both activates Akt and inhibits Akt through Mek/Erk.
When a Mek inhibitor is present, FGF stimulates Akt activation. When CAPE is present, FGF-stimu-
lated Akt activation is inhibited, and the negative effect of Mek/Erk on Akt is dominant, leading to
decreased Akt phosphorylation. Consistent with this model, the effect of CAPE on Akt phosphoryla-
tion was blunted upon Mek inhibition.
The direct target of CAPE is yet to be determined, but CAPE likely acts upstream of PI3K. CAPE
does not inhibit phosphorylation of membrane-targeted Akt1, so it acts upstream of PIP3, which
recruits Akt to the cell membrane (Figure 5A). Hence CAPE could either activate Pten or inhibit
PI3K. We ruled out Pten activation by showing that CAPE has an identical effect on crestin expres-
sion in wild type or pten null embryos (Figure 6—figure supplement 1E).
Several lines of evidence pointed to Sox10 as a downstream transcription factor affected by
CAPE. We found that CAPE treatment decreased chromatin accessibility at Sox10 binding sites,
including the promoter of mitfa. Furthermore, CAPE’s effects on neural crest gene expression mirror
that of the zebrafish colourless mutant in which sox10 is disrupted: sox10 expression is slightly
reduced, while expression of mitfa and its target genes are dramatically reduced (Dutton et al.,
2001). The dramatic reduction in both crestin and mitfa expression in CAPE-treated embryos is con-
sistent with a reduction in Sox10 activity. While Mitf expression depends on both Pax3 and Sox10,
only Sox10 binding sites are essential for crestin expression, while Pax3 binding sites are dispensable
(Potterf et al., 2000; Elworthy et al., 2003; Kaufman et al., 2016). CAPE-treated embryos also
show an otic vesicle defect that is similar but not identical to colourless. Like sox10 genetic defi-
ciency, CAPE treatment causes a lack of semicircular canal projects and smaller, more closely spaced
otoliths, but it does not decrease otic vesicle size, as has been observed in sox10 mutants
(Dutton et al., 2009). Notably, not all phenotypes of colourless are recapitulated by CAPE treat-
ment, and CAPE treatment causes defects that are not explained by either Sox10 or Akt deficiency.
CAPE likely has other biological targets that explain defects such as body curvature and brain ventri-
cle enlargement. While colourless mutants almost entirely lack pigment cells, CAPE primarily affects
melanocytes. CAPE may reduce Sox10 activity selectively depending on the target gene, with mitfa
being one of the most strongly affected genes. One sox10 mutant, sox10baz1, also has a strong
melanocyte defect and weak xanthophore and iridophore defect (Delfino-Machı´n et al., 2017). This
mutation causes a single amino acid substitution in the HMG DNA-binding domain of Sox10. Both
CAPE and sox10baz1 may selectively affect the activity of Sox10 toward specific target genes, though
CAPE’s effect could be indirect. CAPE has also been reported to reduce mitfa binding to DNA,
which could be a secondary mechanism by which CAPE reduces mitfa target gene expression in
addition to the reduced mitfa levels that we observed (Lee et al., 2013)
Migration defects in CAPE-treated embryos may be downstream of decreased mitfa expression,
as in colourless mutants, but more direct mechanisms for inhibition of migration downstream of Akt
could also play a role. Recent studies have proposed the existence of leader cells with a distinct
gene expression profile that initiate neural crest migration (McLennan et al., 2015;
Richardson et al., 2016). Leader cells are reported to depend on PI3K signaling for maintenance of
polarity, and PI3K is known to activate Rac, a GTPase important for directed cell migration
(Yamaguchi et al., 2015). Akt can also directly phosphorylate cytoskeletal filaments and their regula-
tors, resulting in either enhancement or repression of migration depending on context (Cant-
ley, 2002). CAPE likely has an additional effect on cell migration beyond the neural crest.
We found that both CAPE treatment and constitutively active PTEN reduced the ability of Sox10
to stimulate crestin expression. Sox10 activity might be modified directly, through its binding part-
ners, or through chromatin modification at its binding sites. For example, Akt inhibition could alter
Figure 6 continued
Figure supplement 2—source data 1. Scoring of crestin expression by ISH with kinase inhibitor treatment.
DOI: https://doi.org/10.7554/eLife.29145.051
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Figure 7. Akt signaling regulates neural crest gene expression in vivo. (A) PTEN QMA-mCherry (300 pg) reduces phospho-Akt level in whole embryos.
(B) Morphology, PTEN QMA-mCherry expression, and crestin:EGFP expression of PTEN QMA-mCherry injected embryos. Scoring system for crestin:
EGFP levels is indicated. (C) Quantification based on scoring in (B). Each point represents a single clutch (5–53 embryos per condition), and mean is
indicated. One clutch generated less than 5 PTEN QMA-mCherry low embryos and is not shown. *p<0.01, Student’s t-test (D) PTEN QMA-mCherry
Figure 7 continued on next page
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Sox10 dimerization or Sox10-Pax3 interaction, both of which are known to affect expression of
Sox10 target genes (Lang et al., 2000; Bondurand et al., 2000; Potterf et al., 2000). Akt can
directly phosphorylate transcription factors to regulate their activity, as was shown with Twist-1 in
tumor cells (Vichalkovski et al., 2010). Whether CAPE treatment and Akt inhibition affect Sox10
activity directly or indirectly will be an interesting area for future study.
Our data suggests that CAPE treatment and inhibition of Akt signaling block neural crest differen-
tiation. Interestingly, a prior study in Xenopus showed an earlier and broader role for Akt in ecto-
derm development (Pegoraro et al., 2015). Pegoraro et al. found that the glycolysis regulator
PFKFB4 is required for specification of all dorsal ectoderm derivatives, including neural and non-neu-
ral ectoderm, neural crest, and placodes, and acts by inhibiting Akt signaling. In contrast, our study
found that inhibition of Akt signaling does not disrupt early neural crest specification but inhibits
subsequent expression of Sox10 target genes, neural crest migration, and pigment cell differentia-
tion. This apparent discrepancy could be the result of species-specific differences, or it could be
related to the specificity of CAPE for inhibition of Akt stimulated by a particular ligand. We showed
that in vitro CAPE inhibits FGF-stimulated Akt activation but not insulin-stimulated Akt activation.
Though our study and that of Pegoraro et al. suggest different roles for Akt signaling in neural crest
development, they both demonstrate that Akt signaling promotes differentiation independently of
its effect on cell survival. A current challenge in neural crest biology is understanding how morpho-
gens connect to gene expression through intracellular signaling pathways and their associated tran-
scription factors. Our study has identified PI3K/Akt as a novel intracellular signaling pathway that
regulates neural crest differentiation through modulation of Sox10 activity. Our findings may also
impact the understanding and treatment of melanoma, as the Sox10 target MITF is a lineage onco-
gene in this neural crest-derived cancer (Garraway et al., 2005).
Materials and methods
Zebrafish husbandry and strains
Zebrafish were maintained under standard protocols approved by the Boston Children’s Hospital
(BCH) Institutional Animal Care and Use Committee (IACUC). Unless indicated otherwise, AB strain
embryos were used for all experiments. Additional zebrafish strains included crestin_1 kb:EGFP
(referred to as crestin:EGFP here) (Kaufman et al., 2016) (RRID:ZFIN_ ZDB-TGCONSTRCT-160208–
1), crestin_296bp:EGFP (Kaufman et al., 2016) (RRID:ZFIN_ ZDB-TGCONSTRCT-160208–2), sox10:
GFP (Curtin et al., 2011) (RRID:ZFIN_ ZDB-ALT-110411–1), sox10:Kaede (Dougherty et al., 2012)
(RRID:ZFIN_ ZDB-FISH-150901–26827), mitfa:GFP (Curran et al., 2009) (RRID:ZFIN_ ZDB-FISH-
150901–12193), ubi:mCherry (Mosimann et al., 2011) (RRID:ZFIN_ ZDB-ALT-110317–3), and casper
(White et al., 2008) (RRID:ZFIN_ ZDB-FISH-150901–6638, ptena-/-ptenb-/- (Faucherre et al., 2008)
(RRID:ZFIN_ ZDB-FISH-150901–12142). Zebrafish embryos were staged according to (Kimmel et al.,
1995).
Figure 7 continued
decreases crestin expression by ISH. Embryos were scored as in Figure 5B. Average score normalized to uninjected control is indicated. Error bars
represent SEM of four clutches (7–28 embryos per condition) from three independent experiments. One clutch was excluded because of abnormally
low staining in both control and injected embryos. (E) The PI3K inhibitor LY294002 decreases crestin:EGFP expression. Points indicate the average of
two independent experiments. (F) PTEN QMA-mCherry prevents Sox10 from stimulating crestin:EGFP expression. Representative embryos from the
same clutch are shown. (G) Three clutches (8–19 embryos per condition) from two independent experiments were scored as in (B).
DOI: https://doi.org/10.7554/eLife.29145.052
The following source data is available for figure 7:
Source data 1. Scoring of crestin:EGFP expression in PTEN QMA-mCherry-injected embryos.
DOI: https://doi.org/10.7554/eLife.29145.053
Source data 2. Scoring of crestin expression by ISH in PTEN QMA-injected embryos.
DOI: https://doi.org/10.7554/eLife.29145.054
Source data 3. Scoring of crestin:EGFP expression in LY294002-treated embryos.
DOI: https://doi.org/10.7554/eLife.29145.055
Source data 4. Scoring of crestin:EGFP in sox10- and PTEN-injected embryos.
DOI: https://doi.org/10.7554/eLife.29145.056
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Heterogeneous neural crest cell culture
Crestin:EGFP; ubi:mCherry transgenic zebrafish embryos were grown to the 5 somite stage, decon-
taminated in 0.05% bleach for 2 min, and dechorionated in 2.5 mg/ml pronase for 5 min. Embryos
were then mechanically homogenized in neural crest medium using a rotor-stator homogenizer
(Omni TH) at 5000 rpm for 10 s. Neural crest medium consisted of a base medium of DMEM/F12
with L-glutamine and 2.438 g/l sodium bicarbonate (Invitrogen #11320) supplemented with 12%
FBS, 1% N2 supplement (Invitrogen #17502), 20 mg/ml insulin (Gemini Bioproducts #700–112P), 20
ng/ml FGF2 (R and D Systems #233-FB-025/CF), 20 ng/ml EGF (R and D Systems #236-EG-200), and
0.2% Primocin (InVivoGen). Embryos were plated at a density of 0.6–1 embryos per 0.1 cm2 (1 well
of a 384 well plate) on standard tissue culture-coated plates and cultured for 24–48 hr under 5%
CO2 at 28.5˚C. N2 was excluded for short term (2 hr) cultures to test the effects of growth factor
stimulation since it contains insulin.
In vitro immunofluorescence, EdU staining, and migration speed
measurement
EdU staining was conducted using the Click-iT EdU Flow Cytometry Assay Kit (Invitrogen). Zebrafish
embryonic cells were plated on collagen, allowed to attach for 24 hr, and treated with 10 mM EdU
for 4 hr. Cells were then fixed in 2% PFA for 30 min at RT, permeabilized in 0.5% Triton-X100/PBS,
and blocked in 5% lamb serum in 0.1% Triton X-100/PBS for 1 hr at RT. Cells were incubated with
primary antibody (AnaSpec anti-GFP #55423, 1:500) in blocking buffer overnight. Cells were washed
4 times and incubated for 2 hr at RT in secondary antibody (Alexa Fluor 488 goat anti-chicken,
1:2000). Cells were washed once, and the Click-iT reaction was performed with Alexa Fluor 647
azide. Cell speed was determined using time lapse fluorescence microscopy of crestin:EGFP+ and
ubi:mCherry+ cells with images acquired every 2 min. The center of each cell was manually tracked
using ImageJ over a period of 4 hr, and the sum of distances migrated per frame was divided by
total imaging time.
Quantitative PCR
RNA was isolated using the RNeasy Plus Mini Kit (Qiagen) according to the manufacturer’s instruc-
tions. RNA was quantified by absorbance at 260 nm and a standard amount was used as input to an
iScript reverse transcriptase reaction (Bio-Rad). The product of this reaction was used for quantitative
PCR at a maximum volume of 1 ml per 10 ml final reaction volume. Quantitative PCR was conducted
using SsoFast EvaGreen Supermix (Bio-Rad) and run on a CFX384 Real-Time System/C1000 Thermal
Cycler (Bio-Rad). Reactions were conducted in triplicate and normalized to b-actin. For each gene,
the sample with the highest expression was assigned a value of 1 and other samples were normal-
ized accordingly. Primer sequences are displayed in Table 2.
Intradermal cell transplantation
Heterogeneous neural crest cell cultures were sorted for DAPI negative, crestin:EGFP+ cells and
resuspended in PBS at a concentration of 10,000 cells/ml. Cell suspension was loaded into a glass
syringe with a 33 gauge needle (Hamilton), and 0.5 ml was injected underneath a scale on the dorsal
flank of a casper fish irradiated with 15 Gy per day for two consecutive days. Transplants were con-
ducted on the third day.
Chemical screening and hit determination
Embryos were plated with chemicals at 5 ss in 384-well plates as described in heterogeneous NC
cultures. Cells were cultured for 1 day, Hoechst 33342 was added at a final concentration of 0.3 mg/
ml, and wells were imaged in red, green, and blue channels on a Nikon Eclipse Ti Spinning Disk Con-
focal. Chemicals libraries included LOPAC1280, a custom bioactives library, FDA-approved drugs,
and Chembridge KINAcore and NHRcore libraries. Chemicals were screened in triplicate at two con-
centrations depending on the library. Hits were identified based on deviation from plate controls in
two values: ratio of crestin:EGFP+/ubi:mCherry+ cells and crestin:EGFP+/total nuclei. All hits were
verified by eye.
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Chemical treatment of zebrafish embryos
Unless otherwise indicated, embryos were treated at 2 ss. To reach this time point, embryos fertil-
ized in the morning were either incubated at 28.5˚C for 12 hr or 23˚C for the first 6 hr of develop-
ment, then transferred to 19˚C overnight. Embryos fertilized in the afternoon were incubated at
23˚C overnight. Chemical stocks were maintained in DMSO, resulting in a final concentration of no
more than 0.3% DMSO in E3 embryo medium. Embryos at a maximum density of 20/well were
treated in 24 well plates in 1 ml of chemical solution at 28.5˚C protected from light. CAPE was
obtained from Tocris (cat #2743) and used at a concentration of 10 mM unless otherwise indicated.
Fluorescence activated cell sorting
Cell sorting was conducted on a BD FACSAria IIu using a nozzle diameter of 80 mm. For whole
embryo FACS, embryos were mechanically homogenized in FACS buffer (2% FBS in PBS), passed
through a 40 mm cell strainer and kept on ice until sorting. DAPI was added at a final concentration
of 1 mg/ml to distinguish live from dead cells. Cells were collected in media or FACS buffer and kept
on ice until further analysis. For crestin:EGFP sorting, the ratio of GFP to PE signal was used to dis-
tinguish autofluorescence from GFP fluorescence.
Imaging of zebrafish embryos
Epifluorescence and bright field images were obtained using a Zeiss Discovery V.8 Stereoscope with
an Axiocam HRc. Confocal microscopy of flat-mounted embryos was conducted on a Nikon C2si
Laser Scanning Confocal. Time lapse confocal microscopy of live embryos was conducted on a Nikon
Table 2. Primer sequences.
Use Gene Forward Reverse Reference
qPCR bactin1 CGAGCAGGAGATGGGAACC CAACGGAAACGCTCATTGC (McCurley and Callard, 2008)
qPCR sox10 ATATCCGCACCTGCACAA CGTTCAGCAGTCTCCACAG
qPCR crestin AGTGCCTGCCAATGTTCAC CTGAAAAAGGCCGATGAGTT
qPCR foxd3 CATGCAAAACAAGCCCAAG ATGAGGGCGATGTACGAGTAG
qPCR mitfa GGCGGTTTAATATCAATGACAGA GGTGCCTTTATTCCACCTCA
qPCR neurog1 CGTGCCATTATCTTCAACACA CGATCTCCATTGTTGATAACCTT
qPCR myf5 GCTACAACTTTGACGCACAAAA CACGATGCTGGACAAACACT










































Ciarlo et al. eLife 2017;6:e29145. DOI: https://doi.org/10.7554/eLife.29145 20 of 26
Research article Developmental Biology and Stem Cells
Eclipse Ti Spinning Disk Confocal. Embryos were mounted on 6 well imaging plates in 0.8% low
melting point agarose containing 0.003% 1-phenyl-2-thiourea (PTU) to prevent pigmentation, 1.6
mg/ml tricaine (MS-222) to immobilize fish, and the relevant concentration of CAPE. Embryos were
maintained at 28.5˚C during imaging.
Whole mount in situ hybridization, immunofluorescence, and TUNEL
Whole mount in situ hybridization was conducted as described (Tallquist and Soriano, 2003;
Thisse and Thisse, 2008; Liu et al., 2002). The following probes were generated from established
plasmids: crestin (Rubinstein et al., 2000), pax3 (Seo et al., 1998), foxd3, sox10, and
snai1b (Thisse et al., 1995). Plasmid templates were linearized using an appropriate restriction
enzyme and PCR purified prior to in vitro transcription. Other in situ probes were generated from
PCR products containing a T7 promoter: tfap2a, tfap2c, inka1a, dlx2a, pax7a, myca, ets1, nr2f2,
msx1b, dlx5a. See Table 2 for primer sequences. RNA was isolated from 17 ss embryos using the
RNeasy Plus Mini Kit (Qiagen). A cDNA library was synthesized using the SuperScript III First Strand
Synthesis System (Invitrogen). PCR was conducted using Phusion High-Fidelity DNA Polymerase
(NEB), and products were purified prior to in vitro transcription with the following components:
Roche Dig 11277073910, BCIP/NBT S3771, Roche T3 or T7 polymerase, RNaseIn (Promega).
For whole mount immunofluorescence, zebrafish embryos were fixed in 4% PFA overnight at 4˚C.
Embryos were permeabilized in acetone at  20˚C for 7 min, blocked for 30 min in blocking buffer
(2% BSA, 10% lamb serum, 1% DMSO in PBS-0.1% Triton X-100) and incubated in primary antibod-
ies in blocking buffer overnight. Embryos were washed twice for 30 min in PBS-0.1% Triton X-100,
then incubated for 2 hr with secondary antibodies at room temperature. Anti-phospho-H3 antibody
was obtained from Santa Cruz Biotechnology (rabbit polyclonal, sc-8656-R, 1:750) and anti-GFP was
from Genetex (chicken polyclonal, GTX13970, 1:500). Secondary antibodies were from Thermo
Fisher (goat anti-rabbit IgG Alexa Fluor 555, goat anti-chicken Alexa Fluor 488, both 1:1000).
Whole mount TUNEL was conducted after crestin in situ hybridization using the ApopTag Peroxi-
dase In Situ Apoptosis Detection Kit (EMD Millipore) with extended incubation times. Signal was
visualized with SIGMAFAST 3,3-Diaminobenzidine tablets (Sigma).
RNA-seq
Total RNA was extracted from sorted sox10:GFP+ cells using Trizol LS according to the manufac-
turer’s instructions. Libraries were prepared using the Ribogone kit (Clontech) and the SMARTer Uni-
versal Low RNA Kit (Clontech) according to the manufacturer’s instructions. Libraries were analyzed
on a Fragment Analyzer (Advanced Analytical) and quantified using the Qubit (Invitrogen) prior to
sequencing on the Illumina HiSeq 2500. Quality control of RNA-Seq datasets was performed by
FastQC and Cutadapt to remove adaptor sequences and low quality regions. The high-quality reads
were aligned to UCSC build danRer7 of the zebrafish genome using Tophat 2.0.11 without novel
splicing form calls. Transcript abundance and differential expression were calculated with Cufflinks
2.2.1. FPKM values were used to normalize and quantify each transcript.
Plasmids
Myr-Akt1 was a gift from William Sellers (Addgene plasmid #9008) (Ramaswamy et al., 1999).
pCSDest was a gift from Nathan Lawson (Addgene plasmid # 22423). PTEN QMA-mCherry was from
Stumpf et al., 2016.
Western blotting
Cultured cells were collected on ice, pelleted at 500 rcf for 3 min at 4˚C, washed once with ice-cold
PBS, and lysed in RIPA buffer containing protease and phosphatase inhibitors. Embryos were
dechorionated, deyolked on ice in 55 mM NaCl, 1.8 mM KCl, 1.3 mM NaHCO3, centrifuged at 500
rcf for 3 min at 4˚C, and washed once in 110 mM NaCl, 3.5 mM KCl, 2.7 mM CaCl2, 10 mM Tris pH
8.5 prior to lysis as for cultured cells. Lysate was centrifuged at 20,000 rcf for 10 min and the super-
natant was collected for analysis of protein concentration with the DC Protein Assay (Bio-Rad). Sam-
ples were boiled in Laemelli buffer before loading of 10 mg protein per well of a 4–20%
polyacrylamide gel. Protein was transferred to a PVDF membrane using the iBlot dry blotting system
(Invitrogen), blocked in 5% milk in TBS with 0.1% Tween 20, and incubated in primary antibody in
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5% BSA overnight at 4˚C. Blots were washed, incubated in horse radish peroxidase (HRP)-conju-
gated secondary antibody for 1 hr at room temperature, washed again, and developed using Amer-
sham ECL Prime Western Blotting Detection Reagent (GE Healthcare) or Pierce ECL Western
Blotting Reagent (Thermo Fisher Scientific). Antibodies were obtained from Cell Signaling: Erk
(#9102, RRID:AB_330744, 1:1000), Akt (#9272, RRID:AB_329827, 1:1000), phospho-Akt (#9271,
RRID:AB_329825, 1:1000), phospho-Erk (#9101, RRID:AB_331646, 1:1000), GAPDH (#2118, RRID:
AB_561053, 1:2000), HRP-linked anti-rabbit IgG (#7074, RRID:AB_2099233, 1:2000).
RNA microinjection
Constructs were cloned into pCSDest (Villefranc et al., 2007), linearized, transcribed using the
Ambion mMessage mMachine SP6 Kit (Thermo Fisher Scientific), and purified with the RNeasy MinE-
lute RNA Cleanup Kit (Qiagen). RNA was quantified based on absorbance at 260 nm and injected
with 0.1% phenol red into 1–2 cell embryos in a volume of 1–2 nl.
ATAC-seq
Cells (12,000–40,000) were pelleted at 500 rcf for 5 min at 4˚C, washed once in ice cold PBS, and
permeabilized in 10 mM Tris-HCl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% IGEPAL CA-360. Libraries
were prepared using the Nextera DNA Preparation Kit (Illumina) with a transposase reaction time of
30–45 min and purified with the MinElute PCR Purification Kit (Qiagen). Quantitative PCR was used
to estimate the total number of cycles needed for library amplification. Libraries were analyzed on a
Fragment Analyzer (Advanced Analytical) and quantified using the Qubit (Invitrogen) prior to
sequencing on the Illumina HiSeq 2500. ATAC-Seq datasets were aligned to UCSC build danRer7 of
the zebrafish genome using Bowtie2 (version 2.2.1) with the following parameters: –end-to-end, -N0,
-L20. We used the MACS2 version 2.1.0 peak finding algorithm to identify regions of ATAC-Seq
peaks, with the following parameter –nomodel –shift  100 –extsize 200. A q-value threshold of
enrichment of 0.05 was used for all datasets. HOMER was used for peak motif analysis (RRID:SCR_
010881).
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